Skip to main content
Premium Trial:

Request an Annual Quote

High Security Lab for Japan

In response to the Ebola outbreak in West Africa and concerns that it might spread, Japan has decided to upgrade one of its infectious disease labs to handle such BSL-4 pathogens, Nature News reports.

Japan's National Institute of Infectious Diseases built the lab, located less than 20 miles outside Tokyo, more than 30 years ago to be a BSL-4 lab, but it has been operating as a BSL-3 lab due to safety concerns, it adds. But worries last year that the Ebola outbreak could reach Japan spurred the decision to revamp it as a working BSL-4 lab.

There are some restrictions on what researchers in the lab will be able to do, however, Nature News reports. For instance, it says that BSL-4 work there will be limited to diagnosing and treating patients. But researchers like Ayato Takada at Hokkaido University hope this will pave the way for scientists to perform basic research in a BSL-4 lab — he currently collaborates with international researchers and flies to the US multiple times a year to use  labs there.

"It's time-consuming and expensive," Takada tells Nature News. "I really hope the decision at Murayama will have a good influence on the likelihood of the Nagasaki University BSL-4 plan."

The Scan

UK Moves to Allow Sale of Gene-Edited Food

The UK is moving ahead to allow the sale of gene-edited food in England, Scotland, and Wales, according to New Scientist.

Questions for the Field

Stat News writes that the alleged Buffalo shooter's citation of genetics research raises questions about what the field can do.

Cell Studies on Tumor Evolution in Mouse Model of Lung Cancer, Stereo-seq, Bacteriophage Responses

In Cell this week: tumor evolution tracked in mouse model of lung cancer, organogenesis mapped using Stereo-seq, and more.

Taking Stock of the Stockpile

The US and European countries are evaluating their smallpox vaccine stockpiles as the number of monkeypox cases increases, the Washington Post reports.